This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Intra-Cellular Therapies, Inc., The Rockefeller University. Active years: 1998-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2022
Title: The Innovative Contributions of Allen Fienberg
Introduction
Allen Fienberg is a prominent inventor based in New York, NY, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Fienberg has made remarkable strides in developing treatments for various medical conditions.
Latest Patents
Fienberg's latest patents include innovative PDE1 inhibitors for ophthalmic disorders. These compounds are designed to inhibit phosphodiesterase 1 (PDE1), which is useful in treating glaucoma and elevated intraocular pressure. The PDE1 inhibitors can be administered as monotherapy or in combination with additional intraocular-pressure lowering agents. Furthermore, his invention provides ophthalmic compositions that comprise PDE1 inhibitors and optionally one or more additional intraocular pressure-lowering agents. Both topical and systemic therapy may be utilized in these treatments. Another notable patent involves methods and compositions for sleep disorders and other related conditions. This patent discloses the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals. These compounds are aimed at treating disorders involving the 5-HT2A, SERT, and/or dopamine D2 pathways. Additionally, the compounds may be combined with other therapeutic agents for the treatment of sleep disorders, depression, psychosis, dyskinesias, and Parkinson's disease.
Career Highlights
Fienberg is currently associated with Intra-Cellular Therapies, Inc., where he continues to innovate and develop new therapeutic solutions. His work has had a significant impact on the pharmaceutical industry, particularly in the areas of ophthalmology and neurology.
Collaborations
Throughout his career, Fienberg has collaborated with notable colleagues, including Sharon Mates and Lawrence P. Wennogle. These partnerships have further enhanced his research and development efforts.
Conclusion
Allen Fienberg's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the development of effective therapies for various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile